STOMACH CANCER

This study is testing a new robotic surgery system with an extra 'fifth arm' for patients with stomach cancer. Ten patients in Hong Kong and Japan will have their cancer removed using this experimental robotic system. The main goals are to see if the surgery can be completed succ…

This study is testing a new drug called 3H-10000 for people with advanced lung or stomach cancer that cannot be removed by surgery or has spread. The main goals are to find a safe dose and to see if the drug can shrink tumors. The study will enroll about 170 adults and is current…

This study is testing whether a combination of two oral drugs, avutometinib and defactinib, can help people live longer and slow the growth of a specific, hard-to-treat type of stomach cancer that has spread. It is for adults whose cancer has continued to grow despite prior chemo…

This is an early-stage study testing the safety of a new type of CAR-T cell therapy called PTC13 in adults with advanced solid tumors that have a marker called CEA. The therapy involves collecting a patient's own immune cells, genetically engineering them in a lab to better targe…

This study is testing whether adding a new drug called ivonescimab to standard chemotherapy (FOLFOX) works better for people with advanced stomach or esophagus cancer that is HER2-negative. The goal is to see if this combination can help control the cancer for longer and shrink t…

This early-stage trial is testing a new drug called CA-4948 in combination with standard chemotherapy and immunotherapy for people with advanced stomach or esophageal cancer that cannot be surgically removed. The study aims to find the safest dose of this combination and see if i…

This study is testing a new blood test to see if it can detect many different types of cancer early, before symptoms appear. It will involve 7,000 people, both with and without cancer, to see if the test can spot cancer signals and identify where in the body the cancer started. T…

This study is testing new radioactive tracers for PET/CT scans to see if they can improve the detection and monitoring of digestive system cancers. Researchers will scan 400 patients with cancers like stomach, colon, or liver cancer to see where the tracers go in the body and how…

This study is testing whether virtual reality (VR) can help reduce pain and improve quality of life for people with gastrointestinal cancers. Researchers will compare three approaches: VR that teaches pain management skills, VR designed to distract from pain, and a basic VR contr…

This study aims to understand how genes and proteins contribute to the development of stomach and esophageal cancers. Researchers will analyze tissue samples from biopsies and blood samples from patients with these cancers or those at high inherited risk. The goal is to gather kn…

This study aims to see if changes in what people buy—like pain relief or digestive aids—can serve as an early warning sign for certain cancers. Researchers will compare the shopping history of 1,450 recently diagnosed cancer patients with 1,450 people without cancer, using up to …